News from the caves: Update on the structure and function of caveolae

Current Opinion in Cell Biology

Volumn 29, Issue 1, 2014, Pages 99-106

  Shvets, Elena ^a   Ludwig, Alexander ^b   Nichols, Benjamin James ^a  

^a MRC LMB ^*  (United Kingdom)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLAR PROTEIN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; DYNAMIN; G PROTEIN COUPLED RECEPTOR; INSULIN RECEPTOR; PROTEIN; PROTEIN KINASE C DELTA; UNCLASSIFIED DRUG;

ADIPOCYTE; BINDING SITE; CAVEOLA; CELL DAMAGE; CELL FUNCTION; CELL MEMBRANE; CELL ULTRASTRUCTURE; CIRCADIAN RHYTHM; ELECTRON MICROSCOPY; ENDOCYTOSIS; ENDOSOME; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FAT INTAKE; FATTY ACID TRANSPORT; HUMAN; INTESTINE BRUSH BORDER MEMBRANE; LIPODYSTROPHY; MECHANICAL STRESS; MEMBRANE DAMAGE; MEMBRANE TRANSPORT; METABOLISM; MUSCLE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STOICHIOMETRY;

ANIMALS; CAVEOLAE; CAVEOLINS; CELL MEMBRANE; ENDOCYTOSIS; HUMANS; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84901981250     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2014.04.011     Document Type: Review

References (100)

1. Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1955, 1:445-458.
2. Palade G.E. Fine structure of blood capillaries. J Appl Phys 1953, 24:1424.
3. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., et al. Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
4. Dietzen D.J., Hastings W.R., Lublin D.M. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem 1995, 270:6838-6842.
5. Hansen C.G., Nichols B.J. Exploring the caves: cavins, caveolins and caveolae. Trends Cell Biol 2010, 20:177-186.
6. McMahon K.A., Zajicek H., Li W.P., Peyton M.J., Minna J.D., et al. SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. Embo J 2009, 28:1001-1015.
7. Hansen C.G., Bright N.A., Howard G., Nichols B.J. SDPR induces membrane curvature and functions in the formation of caveolae. Nat Cell Biol 2009, 11:807-814.
8. Bastiani M., Liu L., Hill M.M., Jedrychowski M.P., Nixon S.J., et al. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J Cell Biol 2009, 22:22.
9. Liu L., Brown D., McKee M., Lebrasseur N.K., Yang D., et al. Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance. Cell Metab 2008, 8:310-317.
10. Hill M.M., Bastiani M., Luetterforst R., Kirkham M., Kirkham A., et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 2008, 132:113-124.
11. Vinten J., Johnsen A.H., Roepstorff P., Harpoth J., Tranum-Jensen J. Identification of a major protein on the cytosolic face of caveolae. Biochim Biophys Acta 2005, 1717:34-40.
12. Koch D., Westermann M., Kessels M.M., Qualmann B. Ultrastructural freeze-fracture immunolabeling identifies plasma membrane-localized syndapin II as a crucial factor in shaping caveolae. Histochem Cell Biol 2012, 138:215-230.
13. Senju Y., Itoh Y., Takano K., Hamada S., Suetsugu S. Essential role of PACSIN2/syndapin-II in caveolae membrane sculpting. J Cell Sci 2011, 124:2032-2040.
14. Hansen C.G., Howard G., Nichols B.J. Pacsin 2 is recruited to caveolae and functions in caveolar biogenesis. J Cell Sci 2011, 124:2777-2785.
15. Stoeber M., Stoeck I.K., Hanni C., Bleck C.K., Balistreri G., et al. Oligomers of the ATPase EHD2 confine caveolae to the plasma membrane through association with actin. EMBO J 2012, 31:2350-2364.
16. Moren B., Shah C., Howes M.T., Schieber N.L., McMahon H.T., et al. EHD2 regulates caveolar dynamics via ATP-driven targeting and oligomerization. Mol Biol Cell 2012, 23:1316-1329.
17. Liu L., Pilch P.F. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J Biol Chem 2008, 283:4314-4322.
18. Hayer A., Stoeber M., Bissig C., Helenius A. Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes. Traffic 2009, 11:361-382.
19. Richter T., Floetenmeyer M., Ferguson C., Galea J., Goh J., et al. High-resolution 3D quantitative analysis of caveolar ultrastructure and caveola-cytoskeleton interactions. Traffic 2008, 9:893-909.
20. Ludwig A., Howard G., Mendoza-Topaz C., Deerinck T., Mackey M., et al. Molecular composition and ultrastructure of the caveolar coat complex. PLoS Biol 2013, 11:e1001640.
21. Shu X., Lev-Ram V., Deerinck T.J., Qi Y., Ramko E.B., et al. A genetically encoded tag for correlated light and electron microscopy of intact cells, tissues, and organisms. PLoS Biol 2011, 9:e1001041.
22. Hansen C.G., Shvets E., Howard G., Riento K., Nichols B.J. Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae. Nat Commun 2013, 4:1831-1838.
23. Moon H., Lee C.S., Inder K.L., Sharma S., Choi E., et al. PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer. Oncogene 2013, 10.1038/onc.2013.315.
24. Jansa P., Grummt I. Mechanism of transcription termination: PTRF interacts with the largest subunit of RNA polymerase I and dissociates paused transcription complexes from yeast and mouse. Mol Gen Genet 1999, 262:508-514.
25. Walser P.J., Ariotti N., Howes M., Ferguson C., Webb R., et al. Constitutive formation of caveolae in a bacterium. Cell 2012, 150:752-763.
26. Hayashi Y.K., Matsuda C., Ogawa M., Goto K., Tominaga K., et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest 2009, 119:2623-2633.
27. Parton R.G., del Pozo M.A. Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol 2013, 14:98-112.
28. Nassoy P., Lamaze C. Stressing caveolae new role in cell mechanics. Trends Cell Biol 2012, 22:381-389.
29. Pilch P.F., Liu L. Fat caves: caveolae, lipid trafficking and lipid metabolism in adipocytes. Trends Endocrinol Metab 2011, 22:318-324.
30. Ardissone A., Bragato C., Caffi L., Blasevich F., Maestrini S., et al. Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy. BMC Med Genet 2013, 14:89.
31. Dwianingsih E.K., Takeshima Y., Itoh K., Yamauchi Y., Awano H., et al. A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4. Mol Genet Metab 2010, 101:233-237.
32. Rajab A., Straub V., McCann L.J., Seelow D., Varon R., et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet 2010, 6:e1000874.
33. -/- mice. Am J Physiol Heart Circ Physiol 2012, 302:H2518-H2527.
34. Austin E.D., Ma L., LeDuc C., Berman Rosenzweig E., Borczuk A., et al. Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension. Circ Cardiovasc Genet 2012, 5:336-343.
35. Mathew R. Pathogenesis of pulmonary hypertension:a case for caveolin-1 and cell membrane integrity. Am J Physiol Heart Circ Physiol 2014, 306:H15-H25.
36. Stralfors P. Caveolins and caveolae, roles in insulin signalling and diabetes. Adv Exp Med Biol 2012, 729:111-126.
37. Gustavsson J., Parpal S., Karlsson M., Ramsing C., Thorn H., et al. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. Faseb J 1999, 13:1961-1971.
38. Siddiqui M.R., Komarova Y.A., Vogel S.M., Gao X., Bonini M.G., et al. Caveolin-1-eNOS signaling promotes p190RhoGAP-A nitration and endothelial permeability. J Cell Biol 2011, 193:841-850.
39. Garcia-Cardena G., Oh P., Liu J., Schnitzer J.E., Sessa W.C. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A 1996, 93:6448-6453.
40. Sinha B., Koster D., Ruez R., Gonnord P., Bastiani M., et al. Cells respond to mechanical stress by rapid disassembly of caveolae. Cell 2011, 144:402-413.
41. Pelkmans L., Burli T., Zerial M., Helenius A. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 2004, 118:767-780.
42. Corrotte M., Almeida P.E., Tam C., Castro-Gomes T., Fernandes M.C., et al. Caveolae internalization repairs wounded cells and muscle fibers. Elife 2013, 2:e00926.
43. Pelkmans L., Puntener D., Helenius A. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 2002, 296:535-539.
44. Galbiati F., Engelman J.A., Volonte D., Zhang X.L., Minetti C., et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem 2001, 276:21425-21433.
45. Joshi B., Bastiani M., Strugnell S.S., Boscher C., Parton R.G., et al. Phosphocaveolin-1 is a mechanotransducer that induces caveola biogenesis via Egr1 transcriptional regulation. J Cell Biol 2012, 199:425-435.
46. Albinsson S., Nordstrom I., Sward K., Hellstrand P. Differential dependence of stretch and shear stress signaling on caveolin-1 in the vascular wall. Am J Physiol Cell Physiol 2008, 294:C271-C279.
47. 2+ waves at caveolae in vascular endothelial cells. J Cell Sci 2011, 124:3477-3483.
48. Pietuch A., Bruckner B.R., Janshoff A. Membrane tension homeostasis of epithelial cells through surface area regulation in response to osmotic stress. Biochim Biophys Acta 2013, 1833:712-722.
49. Milici A.J., Watrous N.E., Stukenbrok H., Palade G.E. Transcytosis of albumin in capillary endothelium. J Cell Biol 1987, 105:2603-2612.
50. Oh P., Borgstrom P., Witkiewicz H., Li Y., Borgstrom B.J., et al. Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol 2007, 25:327-337.
51. Pelkmans L., Helenius A. Endocytosis via caveolae. Traffic 2002, 3:311-320.
52. Pelkmans L., Kartenbeck J., Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001, 3:473-483.
53. Damm E.M., Pelkmans L., Kartenbeck J., Mezzacasa A., Kurzchalia T., et al. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol 2005, 168:477-488.
54. Hayer A., Stoeber M., Ritz D., Engel S., Meyer H.H., et al. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. J Cell Biol 2010, 191:615-629.
55. Engel S., Heger T., Mancini R., Herzog F., Kartenbeck J., et al. Role of endosomes in simian virus 40 entry and infection. J Virol 2011, 85:4198-4211.
56. Oh P., McIntosh D.P., Schnitzer J.E. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 1998, 141:101-114.
57. Henley J.R., Krueger E.W., Oswald B.J., McNiven M.A. Dynamin-mediated internalization of caveolae. J Cell Biol 1998, 141:85-99.
58. Fagerholm S., Ortegren U., Karlsson M., Ruishalme I., Stralfors P. Rapid insulin-dependent endocytosis of the insulin receptor by caveolae in primary adipocytes. PLoS One 2009, 4:e5985.
59. Patel H.H., Murray F., Insel P.A. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol 2008, 167-184.
60. Cheng Z.J., Singh R.D., Marks D.L., Pagano R.E. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids. Mol Membr Biol 2006, 23:101-110.
61. Sharma D.K., Brown J.C., Choudhury A., Peterson T.E., Holicky E., et al. Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol Biol Cell 2004, 15:3114-3122.
62. Lee J., Twomey M., Machado C., Gomez G., Doshi M., et al. Caveolae-mediated endocytosis of conjugated polymer nanoparticles. Macromol Biosci 2013, 13:913-920.
63. Wang Z., Tiruppathi C., Cho J., Minshall R.D., Malik A.B. Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life 2011, 63:659-667.
64. Lin H.Y., Yang Y.T., Yu S.L., Hsiao K.N., Liu C.C., et al. Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection. J Virol 2013, 87:9064-9076.
65. Schaefer R.J., Bonor J.C., Joglekar M.S., van Golen K.L., Nohe A.G. 1,25 Dihydroxyvitamin D3 uptake is localized at caveolae and requires caveolar function. J Biomed Nanotechnol 2013, 9:1707-1715.
66. Wernstedt Asterholm I., Mundy D.I., Weng J., Anderson R.G., Scherer P.E. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metab 2012, 15:171-185.
67. Fernandez-Rojo M.A., Gongora M., Fitzsimmons R.L., Martel N., Martin S.D., et al. Caveolin-1 is necessary for hepatic oxidative lipid metabolism: evidence for crosstalk between caveolin-1 and bile acid signaling. Cell Rep 2013, 4:238-247.
68. Hernandez V.J., Weng J., Ly P., Pompey S., Dong H., et al. Cavin-3 dictates the balance between ERK and Akt signaling. Elife 2013, 2:e00905.
69. Gustincich S., Vatta P., Goruppi S., Wolf M., Saccone S., et al. The human serum deprivation response gene (SDPR) maps to 2q32-q33 and codes for a phosphatidylserine-binding protein. Genomics 1999, 57:120-129.
70. Izumi Y., Hirai S., Tamai Y., Fujise-Matsuoka A., Nishimura Y., et al. A protein kinase Cdelta-binding protein SRBC whose expression is induced by serum starvation. J Biol Chem 1997, 272:7381-7389.
71. Tahir S.A., Yang G., Goltsov A., Song K.D., Ren C., et al. Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer. Cancer Res 2013, 73:1900-1911.
72. Zhang H., Links P.H., Ngsee J.K., Tran K., Cui Z., et al. Localization of low density lipoprotein receptor-related protein 1 to caveolae in 3T3-L1 adipocytes in response to insulin treatment. J Biol Chem 2004, 279:2221-2230.
73. Yamamoto H., Sakane H., Yamamoto H., Michiue T., Kikuchi A. Wnt3a and Dkk1 regulate distinct internalization pathways of LRP6 to tune the activation of beta-catenin signaling. Dev Cell 2008, 15:37-48.
74. Yamamoto H., Komekado H., Kikuchi A. Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin. Dev Cell 2006, 11:213-223.
75. Collins B.M., Davis M.J., Hancock J.F., Parton R.G. Structure-based reassessment of the caveolin signaling model: do caveolae regulate signaling through caveolin-protein interactions?. Dev Cell 2012, 23:11-20.
76. Schneider K., Kocher T., Andersin T., Kurzchalia T., Schibler U., et al. CAVIN-3 regulates circadian period length and PER:CRY protein abundance and interactions. EMBO Rep 2012, 13:1138-1144.
77. Siddiqi S., Sheth A., Patel F., Barnes M., Mansbach C.M. Intestinal caveolin-1 is important for dietary fatty acid absorption. Biochim Biophys Acta 2013, 1831:1311-1321.
78. Simard J.R., Meshulam T., Pillai B.K., Kirber M.T., Brunaldi K., et al. Caveolins sequester FA on the cytoplasmic leaflet of the plasma membrane, augment triglyceride formation, and protect cells from lipotoxicity. J Lipid Res 2010, 51:914-922.
79. Meshulam T., Simard J.R., Wharton J., Hamilton J.A., Pilch P.F. Role of caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry 2006, 45:2882-2893.
80. Trigatti B.L., Anderson R.G., Gerber G.E. Identification of caveolin-1 as a fatty acid binding protein. Biochem Biophys Res Commun 1999, 255:34-39.
81. Ring A., Le Lay S., Pohl J., Verkade P., Stremmel W. Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts. Biochim Biophys Acta 2006, 1761:416-423.
82. Razani B., Combs T.P., Wang X.B., Frank P.G., Park D.S., et al. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 2002, 277:8635-8647.
83. Wang H., Wang A.X., Liu Z., Chai W., Barrett E.J. The trafficking/interaction of eNOS and caveolin-1 induced by insulin modulates endothelial nitric oxide production. Mol Endocrinol 2009, 23:1613-1623.
84. Shaul P.W., Smart E.J., Robinson L.J., German Z., Yuhanna I.S., et al. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 1996, 271:6518-6522.
85. Ayala G., Morello M., Frolov A., You S., Li R., et al. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression. J Pathol 2013, 231:77-87.
86. Goetz J.G., Minguet S., Navarro-Lerida I., Lazcano J.J., Samaniego R., et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 2011, 146:148-163.
87. Goetz J.G., Lajoie P., Wiseman S.M., Nabi I.R. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Rev 2008, 27:715-735.
88. Kurzchalia T.V., Dupree P., Parton R.G., Kellner R., Virta H., et al. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J Cell Biol 1992, 118:1003-1014.
89. Drab M., Verkade P., Elger M., Kasper M., Lohn M., et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452.
90. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 2001, 276:38121-38138.
91. Scherer P.E., Okamoto T., Chun M., Nishimoto I., Lodish H.F., et al. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc Natl Acad Sci U S A 1996, 93:131-135.
92. Razani B., Wang X.B., Engelman J.A., Battista M., Lagaud G., et al. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol 2002, 22:2329-2344.
93. Way M., Parton R.G. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 1996, 378:108-112.
94. Tang Z., Scherer P.E., Okamoto T., Song K., Chu C., et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996, 271:2255-2261.
95. Tagawa M., Ueyama T., Ogata T., Takehara N., Nakajima N., et al. MURC, a muscle-restricted coiled-coil protein, is involved in the regulation of skeletal myogenesis. Am J Physiol Cell Physiol 2008, 295:C490-C498.
96. Ogata T., Ueyama T., Isodono K., Tagawa M., Takehara N., et al. MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance. Mol Cell Biol 2008, 28:3424-3436.
97. Ritter B., Modregger J., Paulsson M., Plomann M. PACSIN 2, a novel member of the PACSIN family of cytoplasmic adapter proteins. FEBS Lett 1999, 454:356-362.
98. Herrnberger L., Seitz R., Kuespert S., Bosl M.R., Fuchshofer R., et al. Lack of endothelial diaphragms in fenestrae and caveolae of mutant Plvap-deficient mice. Histochem Cell Biol 2012, 138:709-724.
99. Stan R.V., Ghitescu L., Jacobson B.S., Palade G.E. Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol 1999, 145:1189-1198.
100. Stan R.V., Tse D., Deharvengt S.J., Smits N.C., Xu Y., et al. The diaphragms of fenestrated endothelia: gatekeepers of vascular permeability and blood composition. Dev Cell 2012, 23:1203-1218.